Boston Scientific news
The WiseView Research desk's stories that name Boston Scientific, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The BSX page →
- HeadlineBSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
- HeadlineBoston Scientific Corporation (BSX) Q3 2026 Earnings Call Transcript
- HeadlineCompared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics
- HeadlineBoston Scientific (BSX) Q3 Earnings Match Estimates
- Pre-market reportPre-Market: Fed Decision Looms as Vertiv Jumps, Boston Scientific Slides
Futures point modestly higher ahead of today's Fed rate decision, with Vertiv surging on earnings and Boston Scientific sliding.
- HeadlineBoston Scientific Cuts View Again After Cyberattack, Other Challenges
- HeadlineBoston Scientific Warned You. It Slashed Earnings Guidance After Cyberattack Hit Its Business.
- HeadlineBoston Scientific announces results for third quarter 2026
- HeadlineBoston Scientific to participate in Stifel's 2026 Healthcare Conference
- Week aheadWeek Ahead: Fed Decision, GDP, PCE Inflation and Peak Earnings Week
The Fed's rate decision, Q3 GDP and core PCE inflation headline a week in which 178 S&P 500 companies report earnings.
- HeadlineInsights Into Boston Scientific (BSX) Q3: Wall Street Projections for Key Metrics
- HeadlineBoston Scientific: A Q3 Earnings Miss Likely Amid Product Recall, Cybersecurity Incident
- HeadlineBoston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
- HeadlineBoston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
- HeadlineBSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?
- HeadlineBoston Scientific (BSX) Rises Higher Than Market: Key Facts
- HeadlineWhy Boston Scientific (BSX) Outpaced the Stock Market Today
- CongressRo Khanna sold $1,001 - $15,000 of BSX
- CongressRo Khanna sold $1,001 - $15,000 of BSX
- HeadlineBoston Scientific (BSX) Advances While Market Declines: Some Information for Investors
- HeadlineBoston Scientific Corporation (BSX) is Attracting Investor Attention: Here is What You Should Know
- HeadlineBoston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
- HeadlineBoston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know
- HeadlineBoston Scientific's MedSurg Diversification Bolsters Growth Prospects
- HeadlineBoston Scientific: Market Pessimism Has Pushed The Stock Into Undervalued Territory
- CongressKevin Hern sold $15,001 - $50,000 of BSX
- CongressKevin Hern sold $1,001 - $15,000 of BSX
- CongressKevin Hern sold $50,001 - $100,000 of BSX
- CongressKevin Hern sold $50,001 - $100,000 of BSX
- CongressGilbert Cisneros bought $1,001 - $15,000 of BSX
- CongressRo Khanna bought $1,001 - $15,000 of BSX
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.